Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies

With the development of anti-tumor drugs, tyrosine kinase inhibitors (TKIs) are an indispensable part of targeted therapy. They can be superior to traditional chemotherapeutic drugs in selectivity, safety, and efficacy. However, they have been found to be associated with serious adverse effects in u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mengfei Cheng, Fang Yang, Jiahui Liu, Dan Yang, Shuo Zhang, Yang Yu, Shuai Jiang, Mei Dong
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/55ad76f9d3e0435eaee247780c1c1fba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!